Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quanti OBR: Gadoquatrane vs Approved Macrocyclic GBCAs for MRI in Adults
NCT05915728Phase 3Completed
- Sponsor
- Bayer
- Start
- Jul 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of gadoquatrane, sponsored by Bayer. Started Jul 2023; status: completed.
02
Drugs
gadoquatrane
Beyond the preview
Go deeper on NCT05915728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05915728.